Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
preGO: Aspirin + LMWH vs Aspirin Alone for Preeclampsia Prevention
NCT07361679Phase 4Recruiting
- Sponsor
- Alexandra Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tinzaparin in preeclampsia, sponsored by Alexandra Hospital. Started Jan 2023; status: recruiting.
02
Drugs
tinzaparin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07361679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07361679.